Related Experiment Video
Updated: Dec 18, 2025

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
Levi G Cleare1, Kevin L Li2, Waleed M Abuzeid3
1Department of Medicine (Division of Infectious Diseases) and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Abstract:
Candida auris (C. auris) is an emerging pathogenic fungal species that is especially worrisome due to its high mortality rates and widespread antifungal resistance. Previous studies have demonstrated the efficacy of nitric oxide (NO) nanoparticles on Candida species, and, to our knowledge, this is the first study to investigate the antifungal effects of a NO-generating nanoparticle on C. auris. Six C. auris strains were incubated with a nanoparticle (NAC-SNO-np), which releases N-acetylcysteine S-nitrosothiol (NAC-SNO) and N-acetylcysteine (NAC), and generates NO, through colony forming unit (CFU) assays, and confocal laser scanning microscopy. NAC-SNO-np effectively eradicates planktonic and biofilm C. auris. Across all six strains, 10 mg/mL NAC-SNO-np significantly reduced the number of CFUs (p < 0.05) and demonstrated a >70% decrease in biofilm viability (p < 0.05). NAC-SNO-np effectively eradicates planktonic C. auris and significantly reduces C. auris biofilm formation. Hence, this novel NO-releasing nanoparticle shows promise as a future therapeutic.
Insights
A novel nitric oxide (NO)-generating nanoparticle effectively eradicates the emerging fungal pathogen Candida auris. This innovative treatment significantly reduces both planktonic cells and biofilms, showing promise for future antifungal therapies.
Area of Science:
- Medical Mycology
- Nanotechnology
- Antimicrobial Research
Background:
- Candida auris is a concerning emerging fungal pathogen with high mortality and antifungal resistance.
- Previous research indicates nitric oxide (NO) nanoparticles are effective against Candida species.
- This study is the first to explore NO-generating nanoparticles against C. auris.
Purpose of the Study:
- To investigate the antifungal efficacy of a novel nitric oxide (NO)-generating nanoparticle against Candida auris.
- To evaluate the nanoparticle's effect on both planktonic and biofilm forms of C. auris.
Main Methods:
- Six strains of C. auris were treated with a nitric oxide (NO)-releasing nanoparticle (NAC-SNO-np).
- Colony forming unit (CFU) assays were used to quantify viable C. auris cells.
- Confocal laser scanning microscopy was employed to assess biofilm viability.
Main Results:
- NAC-SNO-np demonstrated significant eradication of planktonic C. auris across all tested strains.
- A concentration of 10 mg/mL NAC-SNO-np significantly reduced CFU counts (p < 0.05).
- The nanoparticle achieved a >70% decrease in C. auris biofilm viability (p < 0.05).
Conclusions:
- The NO-generating nanoparticle NAC-SNO-np is effective against planktonic C. auris.
- NAC-SNO-np significantly inhibits C. auris biofilm formation.
- This novel NO-releasing nanoparticle presents a promising therapeutic candidate for C. auris infections.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Gene Regulation in Microbial Communities: Quorum Sensing
Microorganisms in Medicine and Therapeutics
Antihypertensive Drugs: Vasodilators

